Institut Pasteur, Paris
Chlamydia trachomatis is a human-adapted pathogen and develops exclusively inside a vacuolar compartment. The bacteria control the behavior of the epithelial cells they infect by secreting dedicated ‘effector’ proteins in the host cytoplasm. By combining novel tools (e.g. genetically modified Chlamydia strains) and techniques (culture of primary epithelial cells in organoids, reconstruction of the Fallopian tube-on-chip), the post-doctoral fellow will investigate the function of several effector proteins during C. trachomatis infection.
Genoscope – CEA, Evry
The BEMOD project, funded by the French National Research Agency (ANR), aims to identify proteins and understand the mechanisms involved in the propagation of bacteriophages with modified DNA. We focused on bacteriophages containing a total substitution of their genomic adenine (A) with aminoadenine (Z) resulting in a Z:T base pairing with 3 hydrogen bonds.
IRMB, Montpellier
The project brings together multiple partners across four European countries and aims to develop novel therapeutic and vaccine strategies against West Nile virus (WNV), with a strong focus on antibody-based approaches. IRMB is a multidisciplinary research institute dedicated to the development of innovative immunotherapies.
Immunologie, Immunopathologie et Chimie Thérapeutique, Strasbourg
As part of the team 'physiopathological interactions between the immune system and its microenvironment' in the CNRS research unit UPR3572 "Immunology, Immunopathology and Therapeutic Chemistry " (I2CT) at IBMC, the candidate will be responsible for isolating and culturing primary cells and cell lines, and analysing them by flow cytometry and single-cell transcriptomics.